NEUMORA THERAPEUTICS INC: IND APPLICATION FOR NMRA-215 (NLRP3 INHIBITOR) SUBMITTED TO U.S. FOOD AND DRUG ADMINISTRATION

Reuters · 2d ago

Please log in to view news